Articles
December 5, 2024
Celebrating a Decade on The Boston Globe’s Top Place to Work List
Alnylam Named a Best Place to Work for the 10th Year in a Row by The Boston Globe
Read More ›
October 22, 2024
Driven by Science: Alnylam Named a Science Magazine Top Employer 6 Years in a Row
Lorem ipsum
Read More ›
October 3, 2024
Better Together: Collaborating for Rare Disease Care, Pharmacy Innovation Network
One critical way to address this goal is through strategic collaborations such as the Pharmacy Innovation Network (PIN),
Read More ›
September 26, 2024
Confronting the World’s Leading Killer with a New Therapeutic Approach
For Xicang Guo and Jiaming Zhang, one particular condition remains stubbornly beyond their control – hypertension, also known as high blood pressure.
Read More ›
September 12, 2024
RNAi Therapeutics, from Possibility to Patients
The story of an innovative approach to silencing disease that’s improving lives and changing expectations for medicine.
Read More ›
September 10, 2024
Alnylam Named a Best Workplace for Innovators for the 4th Year in a Row by Fast Company
Alnylam has been named a Fast Company Best Workplace for Innovators for 2024, our 4th year in a row on the list.
Read More ›
August 15, 2024
Alnylam Named a Humankind 100 Company for the 3rd Year in a Row
Alnylam has been named to the HumanKind 100 list for the 2nd year in a row and we’re pleased to have moved up in the rankings from #97 in 2022 to #76 in 2023.
Read More ›
May 7, 2024
Alnylam Publishes 2023 Corporate Responsibility Report
Alnylam's 2023 Corporate Responsibility Report details our corporate responsibility and ESG efforts and progress.
Read More ›
April 26, 2024
Better Together: Alnylam and Organized Customer Health Systems Want to Improve Access and ...
Alnylam's Head of Strategic Accounts discusses the rise of the Integrated Delivery Network and manufacturer relationship
Read More ›
April 25, 2024
Our Commitment to Patients Means Never Stop Evolving - Our Patient Access Philosophy
Tolga Tanguler, Alnylam's Chief Commercial Officer discusses Alnylam's Patient Access Philosophy and approach to access
Read More ›
